259 related articles for article (PubMed ID: 31607242)
1. Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.
Kim SM; Jung JM; Kim BJ; Lee JS; Kwon SU
Stroke; 2019 Dec; 50(12):3503-3511. PubMed ID: 31607242
[TBL] [Abstract][Full Text] [Related]
2. Aspirin plus clopidogrel
Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
[No Abstract] [Full Text] [Related]
3. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
4. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons.
Huang HP; Lin WH; Chen SG; Chen LZ; Chen MY; Che CH
Mol Neurobiol; 2017 Mar; 54(2):1456-1466. PubMed ID: 26846361
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis.
Yang Y; Huang Z; Zhang X
Medicine (Baltimore); 2021 Dec; 100(50):e27804. PubMed ID: 34918630
[TBL] [Abstract][Full Text] [Related]
8. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Shah J; Liu S; Yu W
Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
[TBL] [Abstract][Full Text] [Related]
9. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
10. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis.
Paciaroni M; Ince B; Hu B; Jeng JS; Kutluk K; Liu L; Lou M; Parfenov V; Wong KSL; Zamani B; Paek D; Min Han J; Del Aguila M; Girotra S
Cardiovasc Ther; 2019; 2019():1607181. PubMed ID: 31867054
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.
Xie W; Zheng F; Zhong B; Song X
J Am Heart Assoc; 2015 Aug; 4(8):e002259. PubMed ID: 26304937
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
[TBL] [Abstract][Full Text] [Related]
13. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
15. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
16. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
[TBL] [Abstract][Full Text] [Related]
17. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.
Uchiyama S; Toyoda K; Omae K; Saita R; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T
J Am Heart Assoc; 2021 Oct; 10(20):e022575. PubMed ID: 34622679
[TBL] [Abstract][Full Text] [Related]
18. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial.
Lee CH; Lee JY; Park GM; Lee SW; Kim HS; Choi YJ; Nam CW; Cho JH; Shin WY; Seo JB; Choi SW; Lee JH; Min PK; Her SH; Lee PH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
Am J Cardiol; 2018 Feb; 121(4):423-429. PubMed ID: 29273207
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
Kamal AK; Naqvi I; Husain MR; Khealani BA
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD008076. PubMed ID: 21249700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]